PMC3806678_01
Findings of dynamic computed tomography of the abdomen (early phase). b Diffusion-weighed magnetic resonance imaging showed a markedly hyperintense signal. c Defect re-perfusion imaging of enhanced abdominal ultrasonography showed a hypervascular solid part of the tumor.
crg-0007-0414-g01.jpg
PMC3806678_01_crg-0007-0414-g01.jpg
F1
After the injection of intravenous contrast, the T1-weighted image showed peripheral ring enhancement on both early (fig. 1a) and delayed phases. Defect re-perfusion imaging showed that the solid part of the tumor was hypervascular (fig. 1c). 3D volumetric analysis showed that the total liver volume was 1,041 ml (right lobe 660 ml, left lobe 381 ml); the tumor volume was 24 ml (fig. 2).
3D volumetric analysis showed the total volume of the liver and the tumor.
crg-0007-0414-g02.jpg
PMC3806678_01_crg-0007-0414-g02.jpg
F2
Defect re-perfusion imaging showed that the solid part of the tumor was hypervascular (fig. 1c). 3D volumetric analysis showed that the total liver volume was 1,041 ml (right lobe 660 ml, left lobe 381 ml); the tumor volume was 24 ml (fig. 2).
a The photograph of the cut surface of the liver containing the tumor shows a yellowish-white, mass-forming solid tumor (arrow). The background liver is non-cirrhotic. b Pathologic findings. Photomicrograph (original magnification x40; hematoxylin-eosin stain) of the tumor periphery shows a moderately differentiated adenocarcinoma with marked periductal fibrosis.
crg-0007-0414-g03.jpg
PMC3806678_01_crg-0007-0414-g03.jpg
F3
Grossly, a 5.5 x 4.0 x 3.0 cm well-defined and non-encapsulated solid mass was identified (fig. 3a). Microscopically, the neoplasm was a moderately differentiated adenocarcinoma with abundant fibrous stroma, consistent with a mass-forming CC (fig. 3b).